High-yield overview
Synovium Structure | Type A and B Synoviocytes | Hyaluronic Acid | Boundary and Fluid Film Lubrication
0.1-0.3mmNormal synovium thickness (1-3 cell layers)
3-4 MDaHyaluronic acid molecular weight in normal synovial fluid
0.3-3.5mLNormal synovial fluid volume in knee joint
under 200/μLNormal synovial fluid WBC count
SYNOVIUM STRUCTURE
Intima (Lining)
Pattern1-3 cell layers without basement membrane
TreatmentType A and B synoviocytes
Subintima
PatternLoose connective tissue with vessels
TreatmentFibrous, areolar, or adipose
Type A Synoviocyte
PatternMacrophage-like cell
TreatmentPhagocytosis and debris removal
Type B Synoviocyte
PatternFibroblast-like cell
TreatmentHyaluronic acid synthesis
Critical Must-Knows
- Synovium lacks basement membrane - unique feature allowing bidirectional diffusion for joint nutrition
- Type A synoviocytes are macrophage-like (CD68+) and remove debris via phagocytosis
- Type B synoviocytes are fibroblast-like and synthesize hyaluronic acid for synovial fluid viscosity
- Hyaluronic acid (MW 3-4 MDa) provides non-Newtonian viscosity for lubrication
- Boundary lubrication (lubricin/PRG4) prevents solid-solid contact at low speeds; fluid film lubrication at high speeds
Clinical Pearls
- "Normal synovial fluid is acellular (under 200 WBC/μL) with no organisms on Gram stain
- "Septic arthritis: over 50,000 WBC/μL with over 75% neutrophils, positive culture
- "Inflammatory arthritis: 2,000-50,000 WBC/μL, rheumatoid factor may be present
- "Lubrication mechanisms differ by speed: boundary (static/low speed) vs fluid film (high speed)
Clinical Imaging
Imaging Gallery
Critical Synovial Fluid and Synovium Exam Points
Synovium Structure
Synovium lacks basement membrane - unique feature among body membranes. The intima (lining layer) is 1-3 cells thick with Type A (macrophage-like) and Type B (fibroblast-like) synoviocytes. Subintima is vascular connective tissue.
Hyaluronic Acid Function
Hyaluronic acid (hyaluronan) is a high molecular weight (3-4 MDa) glycosaminoglycan synthesized by Type B synoviocytes. Provides non-Newtonian viscosity: high viscosity at low shear (shock absorption), low viscosity at high shear (ease of movement).
Lubrication Mechanisms
Two lubrication modes: (1) Boundary lubrication by lubricin (PRG4) adsorbed to cartilage surface prevents solid-solid contact at low speeds. (2) Fluid film lubrication by pressurized synovial fluid separates surfaces at high speeds.
Synovial Fluid Analysis
Normal synovial fluid: Clear, yellow, viscous, acellular (under 200 WBC/μL). Septic arthritis: Purulent, over 50,000 WBC/μL, over 75% PMNs, positive culture. Crystal arthropathy: Monosodium urate (gout, negative birefringence), calcium pyrophosphate (pseudogout, positive birefringence).
Mnemonic
TYPE ABTYPE AB - Synoviocyte Functions
| T | Type A = macrophage-like Phagocytosis and debris removal |
| Y | cleY up debris Type A cells clear waste products |
| P | Produces hyaluronic acid Type B fibroblast-like cells synthesize HA |
| E | Essentially no basement membrane Unique synovial feature for diffusion |
| A | A cells have CD68 Macrophage marker on Type A |
| B | B cells are fibroblasts Synthesize matrix proteins |
| T | Type A = macrophage-like Phagocytosis and debris removal | P | Produces hyaluronic acid Type B fibroblast-like cells synthesize HA | A | A cells have CD68 Macrophage marker on Type A |
| Y | cleY up debris Type A cells clear waste products | E | Essentially no basement membrane Unique synovial feature for diffusion | B | B cells are fibroblasts Synthesize matrix proteins |
Hook:TYPE AB blood types remind you: Type A cleans (macrophage), Type B builds (fibroblast)
Mnemonic
HYALURONICHYALURONIC - Hyaluronic Acid Properties
| H | High molecular weight 3-4 million Daltons (3-4 MDa) |
| Y | Yellow clear fluid Normal synovial fluid appearance |
| A | Anionic glycosaminoglycan Negatively charged, attracts water |
| L | Lubrication provider Non-Newtonian viscosity |
| U | Unbranched polymer Linear chain of disaccharides |
| R | Repeating units D-glucuronic acid + N-acetyl-D-glucosamine |
| O | Osmotic properties Attracts water via Donnan effect |
| N | Non-Newtonian Viscosity decreases with shear rate |
| I | Inflammation degrades it Hyaluronidase and free radicals |
| C | Concentration 3-4 mg/mL Normal synovial fluid HA level |
| H | High molecular weight 3-4 million Daltons (3-4 MDa) | L | Lubrication provider Non-Newtonian viscosity | O | Osmotic properties Attracts water via Donnan effect | C | Concentration 3-4 mg/mL Normal synovial fluid HA level |
| Y | Yellow clear fluid Normal synovial fluid appearance | U | Unbranched polymer Linear chain of disaccharides | N | Non-Newtonian Viscosity decreases with shear rate | ||
| A | Anionic glycosaminoglycan Negatively charged, attracts water | R | Repeating units D-glucuronic acid + N-acetyl-D-glucosamine | I | Inflammation degrades it Hyaluronidase and free radicals |
Hook:HYALURONIC = HY molecular weight gives LUBRICation
Mnemonic
BOUNDARYBOUNDARY - Lubrication Mechanisms
| B | Boundary lubrication Lubricin (PRG4) at low speeds |
| O | On cartilage surface Lubricin adsorbs to articular cartilage |
| U | Ultralow friction Coefficient of friction 0.001-0.01 |
| N | No direct solid contact Prevents cartilage wear |
| D | Different from fluid film Two distinct mechanisms |
| A | At static or low speed When fluid film cannot form |
| R | Resist compression Maintains separation under load |
| Y | hYdrophilic brush Lubricin structure prevents adhesion |
| B | Boundary lubrication Lubricin (PRG4) at low speeds | N | No direct solid contact Prevents cartilage wear | R | Resist compression Maintains separation under load |
| O | On cartilage surface Lubricin adsorbs to articular cartilage | D | Different from fluid film Two distinct mechanisms | Y | hYdrophilic brush Lubricin structure prevents adhesion |
| U | Ultralow friction Coefficient of friction 0.001-0.01 | A | At static or low speed When fluid film cannot form |
Hook:BOUNDARY keeps cartilage surfaces apart at the boundary between static and moving
Overview and Introduction
The synovium is a specialized mesenchymal tissue that lines the non-cartilaginous surfaces of synovial joints. It produces synovial fluid, which provides nutrition to avascular articular cartilage and enables nearly frictionless joint motion through sophisticated lubrication mechanisms.
Synovial fluid is a dialysate of plasma enriched with hyaluronic acid (hyaluronan), a high molecular weight glycosaminoglycan that provides unique viscoelastic properties essential for joint function.
Core Concepts
Five concepts unify this topic and recur throughout the basic-science viva:
- The intima has no basement membrane. This unique feature permits bidirectional diffusion that nourishes avascular articular cartilage and allows rapid fluid exchange.
- Two synoviocytes, two jobs. Type A (macrophage-like, CD68+) clear debris and present antigen; Type B (fibroblast-like, vimentin+) synthesise hyaluronan and lubricin.
- Hyaluronan is a glycosaminoglycan, not a proteoglycan (no protein core); its high molecular weight (3-4 MDa) gives synovial fluid non-Newtonian, shear-thinning viscosity.
- Two lubrication regimes. Boundary lubrication (lubricin/PRG4) dominates at low speed/high load; fluid-film lubrication (hyaluronan-rich fluid) dominates at high speed.
- Synovial fluid analysis is diagnostic. Cell count, differential, crystals and culture separate normal, non-inflammatory, inflammatory and septic categories.
Synovium Anatomy and Histology
Macroscopic Anatomy
Location and distribution:
- Lines joint capsule, intra-articular ligaments, and bone surfaces not covered by cartilage
- Does NOT cover articular cartilage or menisci
- Extends to bone-cartilage junction (tidemark region)
- Forms synovial folds (plicae) and villi that increase surface area
Macroscopic appearance:
- Thin membrane (0.1-0.3 mm thickness)
- Smooth, glistening surface
- Pink to pale red color (vascular)
- Highly vascular and innervated
Microscopic Structure
The synovium has two distinct layers:
1. Intima (Lining Layer):
- Thickness: 1-3 cell layers (20-40 micrometers)
- Cell types: Type A and Type B synoviocytes
- NO basement membrane - unique feature allowing bidirectional diffusion
- Intercellular gaps: Allow molecules up to 10-20 nm to pass freely
- Function: Synovial fluid production, nutrition of cartilage, debris removal
2. Subintima (Sublining Layer):
- Structure: Loose connective tissue rich in blood vessels, lymphatics, and nerves
- Three subtypes based on predominant tissue:
- Fibrous (collagenous) - most common, near capsule
- Areolar (loose connective tissue) - most common, near bone
- Adipose (fat tissue) - near fat pads
- Function: Vascular supply, immune surveillance, structural support
Understanding the lack of basement membrane is critical - this allows efficient nutrient exchange for avascular cartilage.
Synovial Fluid Composition and Properties
Synovial Fluid Components
Normal synovial fluid characteristics:
- Volume: 0.3-3.5 mL in knee (varies by joint size)
- Color: Clear to pale yellow (straw-colored)
- Viscosity: High (due to hyaluronic acid)
- Clarity: Transparent (can read newsprint through it)
- Cell count: Under 200 WBC/μL (under 25% neutrophils)
Composition:
1. Plasma dialysate (base fluid):
- Water: 85%
- Electrolytes: Similar to plasma (Na+, K+, Cl-, Ca2+, Mg2+)
- Glucose: 90-100% of plasma glucose (50-100 mg/dL)
- Small molecules diffuse freely from blood
2. Hyaluronic acid (key component):
- Concentration: 3-4 mg/mL (0.3-0.4%)
- Molecular weight: 3-4 million Daltons (3-4 MDa)
- Source: Synthesized by Type B synoviocytes
- Function: Provides viscosity and elasticity
3. Lubricin (PRG4):
- Glycoprotein: 227 kDa molecular weight
- Source: Synthesized by Type B synoviocytes and chondrocytes
- Function: Boundary lubrication, prevents cartilage adhesion
- Concentration: 50-400 micrograms/mL
4. Proteins:
- Total protein: 1-2 g/dL (one-third of plasma protein concentration)
- Albumin: Predominant protein (passes through synovial membrane easily)
- Immunoglobulins: IgG, IgM, IgA present in lower concentrations than plasma
- Enzymes: Collagenase, hyaluronidase (at low levels normally)
5. Cells:
- Total WBC: Under 200/μL (mostly mononuclear)
- Cell types: Monocytes, lymphocytes, synoviocytes (shed from intima)
- No RBCs in normal fluid
Normal synovial fluid is essentially a plasma ultrafiltrate enriched with hyaluronic acid and lubricin.
Joint Lubrication Mechanisms
Two Primary Lubrication Mechanisms
Joints achieve remarkably low friction (coefficient 0.001-0.01) through two complementary mechanisms that operate under different conditions:
1. Boundary Lubrication:
- Active when: Static loading, low sliding speeds, high loads
- Mechanism: Lubricin adsorbed to cartilage surface prevents solid-solid contact
- Lubricant: Lubricin (PRG4) - glycoprotein
- Coefficient of friction: 0.01-0.02
2. Fluid Film Lubrication:
- Active when: High sliding speeds, low to moderate loads
- Mechanism: Pressurized synovial fluid separates opposing cartilage surfaces
- Lubricant: Synovial fluid (water + hyaluronic acid)
- Coefficient of friction: 0.001-0.005
3. Additional mechanisms (contribute but less dominant):
- Weeping lubrication: Fluid exudes from cartilage matrix under load
- Boosted lubrication: HA macromolecules concentrate in gap, increasing viscosity locally
- Hydration lubrication: Hydrated phospholipid layers on cartilage surface
| Feature | Boundary Lubrication | Fluid Film Lubrication |
|---|---|---|
| Active condition | Low speed, high load | High speed, low-moderate load |
| Lubricant | Lubricin (PRG4) | Synovial fluid (HA + water) |
| Mechanism | Adsorbed molecular layer | Pressurized fluid film |
| Friction coefficient | 0.01-0.02 | 0.001-0.005 |
| Example activity | Standing, static loading | Walking, running |
The two mechanisms work together to provide lubrication across the full range of joint activities.
Synovial Fluid Analysis - Clinical Pathology
Classification of Synovial Fluid
| Parameter | Normal | Non-inflammatory | Inflammatory | Septic |
|---|---|---|---|---|
| Color | Clear/pale yellow | Yellow | Yellow/cloudy | Purulent/opaque |
| Clarity | Transparent | Transparent | Translucent/opaque | Opaque |
| Viscosity | High | High | Low | Very low |
| WBC count | under 200/μL | 200-2,000/μL | 2,000-50,000/μL | over 50,000/μL |
| PMN % | under 25% | under 25% | over 50% | over 75% |
| Culture | Negative | Negative | Negative | Positive (50-70%) |
Key diagnostic thresholds:
- Normal: Under 200 WBC/μL
- Non-inflammatory (OA, trauma): 200-2,000 WBC/μL
- Inflammatory (RA, gout, pseudogout): 2,000-50,000 WBC/μL
- Septic: Over 50,000 WBC/μL (classic), but can overlap with inflammatory
Septic Arthritis Diagnosis
Septic arthritis is a surgical emergency. Classic findings: WBC over 50,000/μL, over 75% PMNs, positive Gram stain or culture. However, WBC counts can overlap with inflammatory arthritis. Always correlate with clinical presentation (fever, acute monoarthritis). If suspicion is high, treat as septic until proven otherwise (washout and antibiotics).
Understanding synovial fluid classification guides diagnosis and management.
Pathophysiology of Synovial Diseases
Inflammatory Arthritis (Rheumatoid Arthritis)
Synovial pathology:
- Synovial hypertrophy: Intimal lining proliferates (10-20 cell layers thick vs normal 1-3)
- Pannus formation: Invasive synovial tissue (granulation tissue) erodes cartilage and bone
- Inflammatory infiltrate: Lymphocytes (T and B cells), plasma cells, macrophages in subintima
- Neovascularization: VEGF-driven angiogenesis brings more inflammatory cells
- Cytokine production: TNF-alpha, IL-1, IL-6 drive inflammation and joint destruction
Synovial fluid changes:
- High WBC count: 5,000-50,000/μL (inflammatory range)
- Neutrophil predominance: 50-75% PMNs
- Low viscosity: Hyaluronic acid degraded by hyaluronidase and free radicals
- Low complement: C3 and C4 consumed by immune complexes
- Rheumatoid factor: May be present
Osteoarthritis
Synovial pathology:
- Mild synovitis: Low-grade inflammation (not as severe as RA)
- Fibrosis: Subintimal fibrosis and thickening
- Cartilage fragments: Released into joint, phagocytosed by Type A synoviocytes
Synovial fluid changes:
- Low WBC count: 200-2,000/μL (non-inflammatory)
- Normal to decreased viscosity: HA molecular weight decreases over time
- Cartilage debris: May contain fragments
Septic Arthritis
Synovial pathology:
- Acute inflammation: Massive neutrophil infiltration
- Purulent exudate: Pus formation
- Cartilage destruction: Bacterial enzymes and neutrophil proteases degrade cartilage rapidly
- Vascular thrombosis: Can lead to bone infarction
Synovial fluid changes:
- Very high WBC count: Over 50,000/μL (often over 100,000)
- Neutrophil predominance: Over 75% (often over 90%)
- Positive culture: Staphylococcus aureus most common
- Low glucose: Bacteria consume glucose
- Very low viscosity: Complete HA degradation
Clinical Relevance
Understanding synovial biology directly informs everyday orthopaedic decision-making:
- Septic arthritis is a surgical emergency: bacterial and neutrophil proteases degrade the collagen-proteoglycan matrix within hours, so prompt arthrocentesis, washout and antibiotics preserve cartilage. The synovial WBC count and PMN percentage are the most powerful early laboratory discriminators.
- Crystal arthropathy (gout, CPPD) is diagnosed definitively by polarised-light crystal identification in synovial fluid - and can coexist with infection.
- Osteoarthritis and inflammatory arthritis both degrade hyaluronan (reducing molecular weight and concentration) and lubricin, impairing both fluid-film and boundary lubrication and accelerating wear.
- Pannus in rheumatoid arthritis arises from fibroblast-like (Type B) synoviocyte hyperplasia and macrophage-driven cytokine release, eroding cartilage and bone; this stromal biology is now a therapeutic target (e.g. cadherin-11).
- Lubricin (PRG4) is so central that its genetic loss alone (CACP syndrome) causes precocious, non-inflammatory joint failure - human proof of its protective role and a rationale for PRG4-based therapeutics.
Differential Diagnosis of the Acutely Swollen Joint
The single most important decision after arthrocentesis is distinguishing septic arthritis from its mimics, because untreated infection destroys cartilage within days. Crystals and infection can coexist, so a positive crystal result does NOT exclude sepsis.
| Diagnosis | Typical synovial WBC | PMN % | Discriminating feature | Key action |
|---|---|---|---|---|
| Septic (non-gonococcal) arthritis | over 50,000/μL (often over 100,000) | over 90% | Positive Gram stain/culture; low glucose; raised synovial lactate | Urgent washout + IV antibiotics |
| Gonococcal arthritis | 10,000-60,000/μL | over 75% | Young, sexually active; migratory; tenosynovitis/pustular rash; culture often negative | IV ceftriaxone; screen for STI |
| Gout | 2,000-100,000/μL | 70-95% | Needle crystals, negative birefringence (intracellular) | NSAID/colchicine/steroid; urate-lowering later |
| Pseudogout (CPPD) | 2,000-100,000/μL | 70-95% | Rhomboid crystals, positive birefringence; chondrocalcinosis on X-ray | Treat acute attack; seek metabolic cause |
| Rheumatoid / inflammatory | 2,000-50,000/μL | over 50% | Symmetrical polyarthritis; RF/anti-CCP; low complement | DMARD/biologic; rheumatology referral |
| Osteoarthritis | 200-2,000/μL | under 25% | High viscosity; cartilage debris; no crystals/organisms | Analgesia, load management |
| Haemarthrosis | Bloody/xanthochromic | Variable | Trauma, anticoagulation, haemophilia, PVNS | Treat cause; exclude fracture |
Crystals Do Not Exclude Sepsis
Up to 5% of septic joints contain crystals concurrently. If the clinical picture is septic (fever, rapid onset, raised CRP, immunosuppression), treat as infection regardless of crystal findings until cultures are back.
Guidelines, Registries & Global Practice
Global Epidemiology
Septic arthritis has a global incidence of roughly 4-10 per 100,000 person-years, rising to 30-70 per 100,000 in patients with rheumatoid arthritis or a prosthetic joint. Staphylococcus aureus is the leading pathogen worldwide; in regions with high HIV/TB prevalence, tuberculous and atypical joint infection are proportionally more common. Crystal arthropathy is rising globally: gout now affects 1-4% of adults in high-income countries (driven by ageing, obesity and metabolic syndrome), with the highest prevalence reported in Oceania. Osteoarthritis with secondary synovitis is the commonest cause of chronic joint effusion across all regions.
Side-by-Side Guidance
| Body / Guideline | Scope | Key recommendation | Evidence basis |
|---|---|---|---|
| BSR / BOA (UK, hot swollen joint) | Acute native-joint sepsis | Aspirate BEFORE antibiotics; send urgent microscopy, Gram stain, culture and crystals; treat empirically if sepsis suspected | National guideline, expert consensus + evidence review |
| EULAR (Europe, gout/CPPD) | Crystal arthropathy | Synovial fluid crystal identification by polarised microscopy is the diagnostic gold standard; always exclude co-existing sepsis | Systematic review + consensus (varied levels) |
| AAOS (USA, PJI) | Prosthetic joint infection | Synovial WBC, PMN%, leucocyte esterase and alpha-defensin form a multi-test diagnostic algorithm (MSIS/EBJIS criteria) | Evidence-based, mixed strength |
| ACR (USA, OA) | Osteoarthritis | Conditional recommendation AGAINST intra-articular hyaluronan (viscosupplementation) for knee/hip OA owing to small, uncertain benefit | Strong/conditional GRADE recommendations |
| NICE (UK, OA, NG226) | Osteoarthritis | Do NOT offer intra-articular hyaluronan; intra-articular corticosteroid only for short-term relief | GRADE evidence review |
Practice Variation and Registry Evidence
Viscosupplementation illustrates marked global practice variation: despite a clear biological rationale (Balazs & Denlinger, above), large meta-analyses found only small symptomatic benefit, leading AAOS, ACR and NICE to recommend against routine intra-articular hyaluronan for knee/hip osteoarthritis, while it remains widely used in parts of Europe and Asia. For prosthetic joint infection, synovial fluid criteria are codified differently by the Musculoskeletal Infection Society (MSIS), the European Bone and Joint Infection Society (EBJIS) and AAOS, producing variation in reported infection rates across national arthroplasty registries. National joint registries (e.g. the Australian AOANJRR, the UK National Joint Registry, and Scandinavian registries) track revision for infection as a key outcome, and consistently identify deep infection as a leading cause of early revision after hip and knee arthroplasty.
Aspirate Before Antibiotics
Across the UK (BSR/BOA), European and US guidance, the consistent principle for a hot swollen native joint is to aspirate and culture the joint BEFORE starting antibiotics wherever feasible, because a single dose of antibiotic can render the culture falsely negative and obscure the diagnosis.
Evidence Base
Viscosupplementation: Hyaluronan and Synovial Fluid Rheology
Balazs EA, Denlinger JL • J Rheumatol Suppl (1993)
Key Findings:
- Defined viscosupplementation: restoring the rheological homeostasis of the osteoarthritic joint by replacing degraded endogenous hyaluronan
- Normal synovial fluid is an elastoviscous solution; its high-molecular-weight hyaluronan confers shear-dependent (non-Newtonian) viscosity
- In osteoarthritis the molecular weight and concentration of hyaluronan fall, reducing elastoviscosity and impairing normal joint function
- Intra-articular high-MW hyaluronan augments the depleted fluid compartment to restore lubrication and shock absorption
Clinical Implication: Hyaluronan governs synovial fluid viscoelasticity. Its degradation in arthritis impairs lubrication, providing the conceptual basis for intra-articular viscosupplementation; later high-quality trials, however, show only small symptomatic benefit (see Guidelines section).
Lubricin Deficiency Couples Friction to Cartilage Wear In Vivo
Jay GD, Torres JR, Rhee DK, et al. • Arthritis Rheum (2007)
Key Findings:
- Synovial fluid from humans with genetic lubricin (PRG4) deficiency failed to reduce friction in the boundary mode
- Knee joints of lubricin-null (Prg4-/-) mice showed higher friction and early cartilage wear versus wild-type controls
- Atomic force microscopy showed lubricin self-organises at the surface and reduces the work of adhesion between asperities
- Demonstrated that boundary friction is directly coupled to cartilage surface wear in vivo
Clinical Implication: Provides direct in-vivo evidence that lubricin (PRG4) protects cartilage by lowering boundary friction. Acquired lubricin degradation in inflammatory and post-traumatic joint disease predisposes to wear, underpinning interest in recombinant PRG4 therapeutics.
Basic Science Viva Scenarios
Use these scenarios to practise clinical reasoning and management decisions
CLINICAL SCENARIOStandard
Scenario 1: Synovium Structure and Synoviocyte Types
CLINICAL PROMPT
"Describe the structure of the synovium. What are the two types of synoviocytes and what are their functions?"
PRACTICAL APPROACH
The synovium is a specialized connective tissue that lines synovial joints, consisting of two layers: intima and subintima. The intima is the lining layer, only 1-3 cell layers thick (20-40 micrometers), and uniquely lacks a basement membrane. This allows bidirectional diffusion of nutrients and waste between blood and synovial fluid. The intima contains two cell types: Type A and Type B synoviocytes. Type A synoviocytes are macrophage-like cells derived from bone marrow monocytes. They express macrophage markers like CD68 and have numerous lysosomes for phagocytosis. Their primary function is to remove debris, dead cells, and immune complexes from the joint. They also present antigens and secrete inflammatory cytokines. Type B synoviocytes are fibroblast-like cells of mesenchymal origin. They express fibroblast markers like vimentin and have extensive rough endoplasmic reticulum for protein synthesis. Their primary function is to synthesize hyaluronic acid, which provides synovial fluid viscosity, and lubricin (PRG4) for boundary lubrication. Type B cells also produce collagen for synovial structure. Type B cells are more numerous, making up 70-80% of intimal cells, while Type A cells constitute 20-30%. The subintima is the deeper layer consisting of loose connective tissue rich in blood vessels, lymphatics, and nerves. It provides vascular supply and structural support. The combination of Type A debris removal and Type B lubricant synthesis creates an optimal joint environment.
KEY CLINICAL POINTS
Synovium has two layers: intima (lining, 1-3 cells thick) and subintima (vascular connective tissue)
Intima uniquely lacks basement membrane - allows bidirectional diffusion
Type A synoviocytes: macrophage-like, bone marrow origin, CD68+
Type A function: phagocytosis, debris removal, antigen presentation
Type B synoviocytes: fibroblast-like, mesenchymal origin, vimentin+
Type B function: hyaluronic acid synthesis (viscosity), lubricin synthesis (lubrication)
Ratio: Type B (70-80%) more numerous than Type A (20-30%)
Subintima: vascular, provides nutrients and structural support
COMMON PITFALLS
Not mentioning lack of basement membrane (critical feature)
Confusing Type A and Type B functions
Missing the ratio of Type A to Type B cells
Not explaining how synovium provides nutrition to avascular cartilage
FURTHER QUESTIONS
"What happens to the synovium in rheumatoid arthritis?"
"Why is the lack of basement membrane important?"
"What markers distinguish Type A from Type B cells?"
CLINICAL SCENARIOChallenging
Scenario 2: Joint Lubrication Mechanisms
CLINICAL PROMPT
"Explain the mechanisms of joint lubrication. How do boundary lubrication and fluid film lubrication differ?"
PRACTICAL APPROACH
Synovial joints achieve remarkably low friction (coefficient 0.001-0.01) through two primary mechanisms: boundary lubrication and fluid film lubrication. Boundary lubrication operates at low speeds and high loads. The key molecule is lubricin, also called proteoglycan 4 or PRG4, a 227 kDa glycoprotein synthesized by Type B synoviocytes and superficial zone chondrocytes. Lubricin adsorbs to the articular cartilage surface via its terminal globular domains. The central mucin domain, which is heavily glycosylated, extends perpendicular from the surface creating a molecular brush structure. This brush is highly hydrated. When opposing cartilage surfaces approach under load, the hydrated brushes create steric and hydration repulsion, preventing direct solid-solid contact. During sliding motion, the hydrated layers slide past each other with very low friction (coefficient 0.01-0.02). Boundary lubrication is critical during static loading, slow movements like getting up from a chair, and high loads that squeeze out fluid films. Lubricin deficiency, such as in CACP syndrome due to PRG4 mutations, leads to precocious joint failure. Fluid film lubrication operates at high speeds and moderate loads. It has two subtypes: hydrodynamic and squeeze film. In hydrodynamic lubrication, sliding motion creates a converging wedge that drags synovial fluid into the narrowing gap, generating pressure that lifts the surfaces apart. In squeeze film lubrication, rapid loading squeezes surfaces together but the viscous fluid resists rapid extrusion, temporarily supporting the load. Hyaluronic acid is critical for fluid film lubrication because of its non-Newtonian viscosity - high viscosity at low shear rates provides shock absorption, while low viscosity at high shear rates reduces drag during movement. Normal synovial fluid contains 3-4 MDa hyaluronic acid at 3-4 mg/mL concentration. In osteoarthritis and inflammatory arthritis, hyaluronic acid is degraded by hyaluronidase and free radicals, reducing both molecular weight and concentration. This impairs fluid film lubrication, increasing cartilage contact and wear during walking and running. The two mechanisms are complementary: boundary lubrication protects during low-speed, high-load conditions, while fluid film lubrication provides ultra-low friction during normal activities. Together they enable the remarkable durability of synovial joints.
KEY CLINICAL POINTS
Two primary mechanisms: boundary lubrication and fluid film lubrication
Boundary lubrication: lubricin (PRG4) adsorbed to cartilage surface
Lubricin creates hydrated molecular brush with steric and hydration repulsion
Boundary active at: low speed, high load, static conditions (coefficient 0.01-0.02)
Lubricin deficiency (PRG4 mutations) causes CACP syndrome and early joint failure
Fluid film lubrication: pressurized synovial fluid separates surfaces
Two subtypes: hydrodynamic (wedge) and squeeze film
Hyaluronic acid provides non-Newtonian viscosity (3-4 MDa, 3-4 mg/mL)
Fluid film active at: high speed, moderate load (coefficient 0.001-0.005)
In arthritis: HA degradation impairs fluid film, increases wear
COMMON PITFALLS
Not distinguishing boundary from fluid film mechanisms
Missing lubricin as the key boundary lubricant
Not explaining non-Newtonian viscosity of hyaluronic acid
Forgetting to mention when each mechanism operates
FURTHER QUESTIONS
"What is the structure of lubricin and how does it work?"
"Why is hyaluronic acid non-Newtonian and why does that matter?"
"What happens to lubrication in osteoarthritis?"
CLINICAL SCENARIOStandard
Scenario 3: Synovial Fluid Analysis
CLINICAL PROMPT
"You aspirate synovial fluid from an acutely swollen knee. Describe how you would analyze the fluid and interpret the results."
PRACTICAL APPROACH
Synovial fluid analysis is critical for diagnosing joint pathology. I would assess the fluid systematically. First, gross appearance: normal synovial fluid is clear to pale yellow, transparent, and highly viscous. Cloudy or purulent fluid suggests infection or inflammation. Bloody fluid indicates trauma or hemarthrosis. Second, I would perform a cell count and differential. Normal synovial fluid has under 200 white blood cells per microliter with under 25% neutrophils. Non-inflammatory conditions like osteoarthritis have 200-2,000 WBC/μL. Inflammatory arthritis like rheumatoid arthritis or gout has 2,000-50,000 WBC/μL with over 50% neutrophils. Septic arthritis typically has over 50,000 WBC/μL with over 75% neutrophils, though there is overlap with inflammatory conditions. Third, I would send for Gram stain and culture. Gram stain is positive in 50-70% of bacterial arthritis cases. Culture should be on blood culture agar and chocolate agar with immediate inoculation. For tuberculous arthritis, Lowenstein-Jensen medium is needed, and lymphocytes predominate rather than neutrophils. Fourth, crystal analysis using polarized microscopy is essential. Monosodium urate crystals in gout are needle-shaped with negative birefringence - yellow when parallel to the compensator axis. Calcium pyrophosphate crystals in pseudogout are rhomboid with positive birefringence - blue when parallel to the compensator. Crystals may be intracellular within neutrophils or extracellular. Fifth, additional tests include glucose (under 50% of serum glucose suggests septic arthritis), lactate (over 10 mmol/L suggests septic), and protein (increased in inflammation). In rheumatoid arthritis, complement levels (C3, C4) may be low due to immune complex consumption. The most critical distinction is septic versus non-septic arthritis. If clinical suspicion is high for septic arthritis based on acute presentation, fever, and elevated inflammatory markers, I would treat as septic until proven otherwise with urgent washout and antibiotics, even if WBC count is in the inflammatory range. Delayed treatment of septic arthritis leads to rapid cartilage destruction and poor outcomes.
KEY CLINICAL POINTS
Gross appearance: clear/yellow (normal), cloudy (inflammatory), purulent (septic)
Cell count: under 200 (normal), 200-2,000 (non-inflammatory), 2,000-50,000 (inflammatory), over 50,000 (septic)
Differential: over 75% PMNs suggests septic arthritis
Gram stain (50-70% sensitive) and culture (blood culture agar, immediate inoculation)
Crystal analysis: MSU (gout, needle, negative birefringence), CPP (pseudogout, rhomboid, positive birefringence)
Glucose: under 50% of serum in septic arthritis
Lactate: over 10 mmol/L suggests septic
TB arthritis: lymphocyte predominance, culture on Lowenstein-Jensen
Septic arthritis is surgical emergency - treat if suspicion high despite WBC overlap
COMMON PITFALLS
Not mentioning crystal analysis under polarized microscopy
Confusing positive and negative birefringence
Missing that septic arthritis can have WBC overlap with inflammatory
Not emphasizing urgency of septic arthritis treatment
FURTHER QUESTIONS
"How do you differentiate monosodium urate from calcium pyrophosphate crystals?"
"What is the sensitivity of Gram stain for septic arthritis?"
"When would you suspect tuberculous arthritis?"
Management Algorithm
Algorithm
SYNOVIAL FLUID AND SYNOVIUM
Clinical summary
Synovium Structure
- •Intima: 1-3 cell layers thick (20-40 μm), NO basement membrane (unique feature for diffusion)
- •Subintima: vascular connective tissue (fibrous, areolar, or adipose types)
- •Type A synoviocyte: macrophage-like (CD68+), phagocytosis, 20-30% of intimal cells
- •Type B synoviocyte: fibroblast-like (vimentin+), synthesize HA and lubricin, 70-80% of intimal cells
Synovial Fluid Normal Composition
- •Volume: 0.3-3.5 mL in knee joint
- •Appearance: clear, pale yellow, transparent, highly viscous
- •WBC count: under 200/μL (under 25% neutrophils)
- •Hyaluronic acid: 3-4 mg/mL, 3-4 MDa molecular weight (provides viscosity)
- •Lubricin (PRG4): 50-400 μg/mL (boundary lubrication)
- •Protein: 1-2 g/dL (one-third of plasma)
Hyaluronic Acid
- •Glycosaminoglycan (NOT proteoglycan - no protein core)
- •Repeating disaccharides: D-glucuronic acid + N-acetyl-D-glucosamine
- •MW: 3-4 million Daltons (3-4 MDa) in normal SF
- •Non-Newtonian viscosity: high at low shear (shock absorption), low at high shear (ease of movement)
- •Synthesized by Type B synoviocytes (HAS1/2/3 enzymes)
- •Degraded in arthritis (lower MW and concentration) - impairs fluid film lubrication
Lubrication Mechanisms
- •Boundary lubrication: lubricin (PRG4) adsorbed to cartilage, active at low speed/high load, coefficient 0.01-0.02
- •Fluid film lubrication: pressurized SF separates surfaces, active at high speed, coefficient 0.001-0.005
- •Lubricin: 227 kDa glycoprotein, central mucin domain (hydrated brush), prevents solid-solid contact
- •PRG4 deficiency: CACP syndrome (camptodactyly-arthropathy-coxa vara-pericarditis)
- •Hydrodynamic: wedge film from sliding motion; Squeeze film: viscous resistance to rapid loading
Synovial Fluid Analysis
- •Normal: under 200 WBC/μL, clear, viscous
- •Non-inflammatory (OA): 200-2,000 WBC/μL, under 25% PMNs
- •Inflammatory (RA, gout): 2,000-50,000 WBC/μL, over 50% PMNs
- •Septic: over 50,000 WBC/μL, over 75% PMNs, positive culture (50-90%)
- •Gout: MSU crystals (needle, negative birefringence - yellow when parallel)
- •Pseudogout: CPP crystals (rhomboid, positive birefringence - blue when parallel)
- •Septic markers: glucose under 50% of serum, lactate over 10 mmol/L
Key Clinical Correlations
- •Septic arthritis: surgical emergency, treat if high suspicion (WBC counts overlap with inflammatory)
- •Rheumatoid arthritis: pannus formation (invasive synovium), low complement (C3, C4), ragocytes
- •Osteoarthritis: mild synovitis, HA degradation over time, cartilage fragments in SF
- •Viscosupplementation: exogenous HA injection to restore fluid film lubrication in OA
- •TB arthritis: lymphocyte predominance (not PMNs), culture on Lowenstein-Jensen (6-8 weeks)